Womens Imaging: Page 34

Triple-negative breast cancers impact female populations differently

By Amerigo Allegretto

Despite overall breast cancer rate increases, women of varying race and ethnicity experience disproportionately higher increases.

January 24, 2025

Current topics in mammography

By Sandy Coffta

Sandy Coffta of Healthcare Administrative Partners discusses changes in reporting and reimbursement for mammography exams.

January 17, 2025

CEM has slightly higher mean glandular dose than DBT, mammography

By Amerigo Allegretto

Contrast-enhanced mammography (CEM) has a slightly higher mean glandular dose than other breast imaging modalities.

January 16, 2025

POCUS useful for diagnosis of retained conception tissue

By Amerigo Allegretto

Point-of-care ultrasound (POCUS) can be a useful tool for diagnosing the presence of retained conception tissue.

January 15, 2025

CEM-, radiomics-based models predict breast biopsy outcomes

By Amerigo Allegretto

Machine-learning models combining features from radiomics and contrast-enhanced mammography (CEM) can predict breast biopsy outcomes in women.

January 13, 2025

Genetic testing, risk assessment tied to more breast MRI uptake

By Amerigo Allegretto

Women with high-risk pathological variants for breast cancer as identified by genetic testing and risk assessment are more likely to undergo breast MRI.

January 13, 2025

DBT on par with mammography for imaging referred women

By Amerigo Allegretto

Digital breast tomosynthesis (DBT) has a diagnostic accuracy comparable to digital mammography for women referred for breast imaging.

January 10, 2025

AI-supported mammography is safe and effective in real-world settings

By Amerigo Allegretto

A prospective study found that AI-supported mammography screening is effective in a nationwide, real-world setting.

January 8, 2025

Women with BRCA1/2 germline mutations are often denied breast MRI

By Kate Madden Yee

Women with BRCA1/2 germline mutations are often denied breast MRI -- despite the fact that the exam is recommended for this population.

January 3, 2025

Starting breast cancer screening at 40 is more cost-effective

By Amerigo Allegretto

Starting breast cancer screening at age 40 is tied to improved patient outcomes and reduced healthcare spending on treatment.

January 3, 2025

Deep learning plus DCE-MRI predicts breast cancer treatment response

By Amerigo Allegretto

A deep-learning system based on DCE-MRI can predict pathological complete response in breast cancer patients.

January 2, 2025

2009 USPSTF guidelines not linked to higher breast cancer incidence

By Amerigo Allegretto

Breast cancer screening guidelines issued in 2009 have not led to increased or decreased breast cancer incidence.

December 27, 2024

Previous Page

Page 34 of 713

Next Page